CVRx (CVRX) Competitors $14.13 -0.07 (-0.49%) (As of 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CVRX vs. SMTI, NPCE, SONX, TELA, XAIR, BLFS, ESTA, AORT, MDXG, and PLSEShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Sanara MedTech (SMTI), NeuroPace (NPCE), Sonendo (SONX), TELA Bio (TELA), Beyond Air (XAIR), BioLife Solutions (BLFS), Establishment Labs (ESTA), Artivion (AORT), MiMedx Group (MDXG), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry. CVRx vs. Sanara MedTech NeuroPace Sonendo TELA Bio Beyond Air BioLife Solutions Establishment Labs Artivion MiMedx Group Pulse Biosciences Sanara MedTech (NASDAQ:SMTI) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings. Is SMTI or CVRX more profitable? Sanara MedTech has a net margin of -10.71% compared to CVRx's net margin of -123.75%. Sanara MedTech's return on equity of -19.45% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.45% -11.50% CVRx -123.75%-89.06%-52.56% Do insiders and institutionals hold more shares of SMTI or CVRX? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by insiders. Comparatively, 18.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer SMTI or CVRX? Sanara MedTech presently has a consensus price target of $44.00, indicating a potential upside of 22.22%. CVRx has a consensus price target of $15.83, indicating a potential upside of 12.05%. Given Sanara MedTech's stronger consensus rating and higher probable upside, analysts plainly believe Sanara MedTech is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00CVRx 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71 Does the media favor SMTI or CVRX? In the previous week, Sanara MedTech had 7 more articles in the media than CVRx. MarketBeat recorded 8 mentions for Sanara MedTech and 1 mentions for CVRx. CVRx's average media sentiment score of 1.82 beat Sanara MedTech's score of 0.40 indicating that CVRx is being referred to more favorably in the news media. Company Overall Sentiment Sanara MedTech Neutral CVRx Very Positive Does the MarketBeat Community prefer SMTI or CVRX? CVRx received 9 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 69.23% of users gave CVRx an outperform vote while only 54.55% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes1854.55% Underperform Votes1545.45% CVRxOutperform Votes2769.23% Underperform Votes1230.77% Which has higher earnings & valuation, SMTI or CVRX? Sanara MedTech has higher revenue and earnings than CVRx. Sanara MedTech is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$64.99M4.85-$4.30M-$0.99-36.36CVRx$39.29M8.72-$41.20M-$2.70-5.23 Which has more volatility and risk, SMTI or CVRX? Sanara MedTech has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Comparatively, CVRx has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. SummarySanara MedTech beats CVRx on 11 of the 18 factors compared between the two stocks. Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$342.79M$4.57B$5.34B$8.88BDividend YieldN/A39.52%4.98%4.04%P/E Ratio-5.2324.71132.1317.45Price / Sales8.7261.921,259.0698.78Price / CashN/A52.4439.1436.42Price / Book5.255.526.265.86Net Income-$41.20M$13.58M$118.47M$224.86M7 Day Performance-8.96%-1.82%-2.23%-0.93%1 Month Performance79.31%5.57%2.38%3.66%1 Year Performance-25.59%54.29%35.45%26.41% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx3.0934 of 5 stars$14.13-0.5%$15.83+12.1%-20.3%$342.79M$39.29M-5.23200Positive NewsSMTISanara MedTech1.0706 of 5 stars$34.60-1.1%N/A+30.3%$302.65M$72.41M-44.3660News CoverageNPCENeuroPace3.6899 of 5 stars$7.14-1.9%N/A+7.8%$208.47M$71.82M-6.55170Analyst ForecastNews CoverageGap UpSONXSonendoN/A$2.08+4.0%N/A+588.5%$173.91M$44.40M-4.62250Gap DownTELATELA Bio3.8415 of 5 stars$3.11+5.8%N/A-32.0%$76.86M$64.74M-1.84120Earnings ReportShort Interest ↓XAIRBeyond Air4.5527 of 5 stars$0.49-3.1%N/A-76.2%$23.33M$1.16M-0.3070Earnings ReportHigh Trading VolumeBLFSBioLife Solutions1.7662 of 5 stars$26.50-0.4%N/A+123.7%$1.22B$139.96M-15.68409Analyst ForecastNews CoverageHigh Trading VolumeESTAEstablishment Labs2.2334 of 5 stars$42.38-6.4%N/A+78.3%$1.18B$165.15M-16.43960AORTArtivion2.0706 of 5 stars$27.73-3.9%N/A+100.5%$1.16B$354M-1,386.501,500MDXGMiMedx Group3.0575 of 5 stars$7.46-2.4%N/A+21.3%$1.10B$342.80M13.56895News CoverageGap UpPLSEPulse Biosciences1.7616 of 5 stars$17.74-5.5%N/A+221.4%$1.09B$700,000.000.00140Analyst UpgradePositive News Related Companies and Tools Related Companies SMTI Competitors NPCE Competitors SONX Competitors TELA Competitors XAIR Competitors BLFS Competitors ESTA Competitors AORT Competitors MDXG Competitors PLSE Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CVRX) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
